SKIP TO CONTENT
Johns Hopkins
  • Home
  • About
  • News
  • Contact
  • Login

    • Liquid Biopsy Predicts Response in Patients with Advanced Lung Cancer

    Liquid Biopsy Predicts Response in Patients with Advanced Lung Cancer

    Johns Hopkins researchers are pioneering the use of a “liquid biopsy” to predict which patients with advanced lung cancers are responding to immunotherapies and which patients may develop immune-related side effects several months later.

     READ HERE
    SEE ALL NEWS
    Recent Posts
    In Extensive Sequencing Study, Scientists Find Few Links Between Cancer and Microbiome Johns Hopkins Investigators Create New Urine-based Test to ID Prostate Cancers New therapy kickstarts immune response to cancer Prostate Cancer Treatment: What to Do When It Stops Working 5 Healthy Habits That Help During Cancer Treatment Understanding Mammogram Results A 19-Year Fight Against Prostate Cancer Brings Man to Johns Hopkins Medicine Scientists Advance Efforts to Create ‘Virtual Cell Lab’ As Testing Ground for Future Research with Live Cells Ultra-Processed Foods: Q&A with 2 Dietitians
    Johns Hopkins

    2025 © The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
    Terms of Use Privacy Statement

    LinkedIn
    Back to top